Value
7.7/10data confidence 83%| Component | Sub-score |
|---|---|
| P/S | 8.9 |
| EV/EBITDA | 5.8 |
| Fwd P/E | 8.9 |
| PEG | 10.0 |
| Analyst target | 5.0 |
- ▸Forward P/E: 12.2x
- ▸PEG: 0.06
- ▸Attractively valued
NGVT · Why this verdict
Why Ingevity (NGVT) is rated SELL
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictSELL
Overall score5.6/10
ConfidenceMEDIUM
MacroNEUTRAL
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
The stock has formed a golden cross pattern with the price above all moving averages, RSI at 65, and MACD bullish while on-balance volume is rising — a classic technical breakout configuration. Chart pattern detection | Price breaks above $80 and sustains momentum with RSI remaining above 50 over the next 3 months. | →Stable |
| CounterWith the stock at the analyst target price and only 0.3% upside remaining, there is insufficient price catalyst for continued momentum unless analysts revise targets higher. | ||
Ingevity beat earnings estimates in 3 of the last 4 quarters with an average positive surprise of 17%, including a recent 38% beat, demonstrating consistent ability to exceed analyst expectations in its specialty chemicals operations. Earnings | Ingevity beats consensus EPS in at least 2 of the next 3 quarters and the average positive surprise remains above 10%. | →Stable |
| CounterOne quarter produced a -3% miss, and with the stock already at analyst targets, even a minor miss could trigger meaningful price weakness given the leverage-heavy capital structure. | ||
With a PEG ratio of 0.06 and forward P/E of 12.6x, Ingevity trades at an extreme discount to its earnings growth trajectory, suggesting the market is either discounting the sustainability of growth or pricing in significant leverage risk. Valuation breakdown | The stock re-rates to a forward P/E above 15x as earnings estimates are revised upward following continued beat streaks, implying a price above $86. | →Stable |
| CounterA debt-to-equity ratio of 32x is a severe balance-sheet risk that justifies a compressed multiple, and any earnings deterioration would rapidly impair the company's ability to service debt obligations. | ||
A debt-to-equity ratio of 32x represents extreme financial leverage that leaves virtually no margin for error in earnings delivery and significantly elevates the risk of financial distress in a recessionary or rising-rate environment. Bear case | Debt-to-equity ratio declines below 15x within 18 months as the company directs free cash flow toward debt reduction. | →Stable |
| CounterIf Ingevity's specialty chemicals products maintain stable cash flows and the cost of debt remains manageable, the high leverage may be a permanent structural feature rather than an imminent risk. | ||
The stock has formed a golden cross pattern with the price above all moving averages, RSI at 65, and MACD bullish while on-balance volume is rising — a classic technical breakout configuration.
→StableChart pattern detection
- Expectation
- Price breaks above $80 and sustains momentum with RSI remaining above 50 over the next 3 months.
CounterWith the stock at the analyst target price and only 0.3% upside remaining, there is insufficient price catalyst for continued momentum unless analysts revise targets higher.
Ingevity beat earnings estimates in 3 of the last 4 quarters with an average positive surprise of 17%, including a recent 38% beat, demonstrating consistent ability to exceed analyst expectations in its specialty chemicals operations.
→StableEarnings
- Expectation
- Ingevity beats consensus EPS in at least 2 of the next 3 quarters and the average positive surprise remains above 10%.
CounterOne quarter produced a -3% miss, and with the stock already at analyst targets, even a minor miss could trigger meaningful price weakness given the leverage-heavy capital structure.
With a PEG ratio of 0.06 and forward P/E of 12.6x, Ingevity trades at an extreme discount to its earnings growth trajectory, suggesting the market is either discounting the sustainability of growth or pricing in significant leverage risk.
→StableValuation breakdown
- Expectation
- The stock re-rates to a forward P/E above 15x as earnings estimates are revised upward following continued beat streaks, implying a price above $86.
CounterA debt-to-equity ratio of 32x is a severe balance-sheet risk that justifies a compressed multiple, and any earnings deterioration would rapidly impair the company's ability to service debt obligations.
A debt-to-equity ratio of 32x represents extreme financial leverage that leaves virtually no margin for error in earnings delivery and significantly elevates the risk of financial distress in a recessionary or rising-rate environment.
→StableBear case
- Expectation
- Debt-to-equity ratio declines below 15x within 18 months as the company directs free cash flow toward debt reduction.
CounterIf Ingevity's specialty chemicals products maintain stable cash flows and the cost of debt remains manageable, the high leverage may be a permanent structural feature rather than an imminent risk.
TrendMatrix Research · core thesis
Engine thesis — one sentence
Ingevity Corporation has beaten earnings in 3 of the last 4 quarters, trades at a forward P/E of 12.6x with a PEG of 0.06, and shows strong technical momentum, but with the stock price already at analyst consensus targets and a high debt-to-equity ratio of 32x, the near-term risk/reward is unfavorable.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Per-dimension breakdown
Quality
4.5/10data confidence 100%| Component | Sub-score |
|---|---|
| ROE | 0.0 |
| ROA | 6.0 |
| Gross margin | 3.9 |
| Op margin | 10.0 |
| Net margin | 0.0 |
| Current ratio | 5.3 |
| Moat | 3.9 |
| Piotroski F | 6.7 |
- ▸No competitive moat
Growth
6.8/10data confidence 67%| Component | Sub-score |
|---|---|
| Rev growth | 3.5 |
| EPS growth | 10.0 |
Momentum
5.2/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 5.5 |
| MACD | 8.9 |
| OBV | 1.0 |
| MA position | 9.0 |
| Volume | 1.4 |
- ▸Volume distribution (falling OBV)
- ▸Above 200-day MA
Sentiment
6.3/10data confidence 100%| Component | Sub-score |
|---|---|
| Analyst rating | 6.3 |
| Price target | 7.5 |
| erm sentiment | 5.0 |
- ▸Light analyst coverage (4.0) — signal dampened
Insider
5.0/10data confidence 50%| Component | Sub-score |
|---|---|
| materiality | 5.0 |
| holder change | 5.1 |
- ▸Negligible insider selling — $33,971 (0.001% of mkt cap)
Peer rank
2.2/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 4.1 |
| quality rank | 0.4 |
| growth rank | 4.3 |
Technical
5.5/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 4.3 |
| support resistance | 3.8 |
| 52w position | 8.3 |
Risk (lower is worse)
4.7/10data confidence 100%| Component | Sub-score |
|---|---|
| short interest | 7.8 |
| days to cover | 5.8 |
| volatility | 3.7 |
| put call | 4.9 |
| implied vol | 4.1 |
| beta | 6.3 |
| debt equity | 0.0 |
Catalyst
6.7/10data confidence 100%| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 6.7 |
| earnings timing | 5.0 |
| surprise avg | 10.0 |
- ▸Strong earnings: 3B/1M
How the verdict was assembled
Engine trigger
Multiple concerning factors. Consider reducing position.
Engine technical detail
verdict_path:
L4:PATH_F_SELLPassed (7)
- MOMENTUM:5.2>=4.5
- INSIDER:OK
- 8K:CLEAN
- NEWS_EVENTS:NONE_RECENT
- EARNINGS_PROXIMITY:25d clear
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (1)
- ASYMMETRY:0.0<1.5@spot
Warning (1)
- MOMENTUM:5.2<5.5 (soft — BUY_NOW allowed but watch)
Reward-to-Risk
0.02
Upside
+0.3%
Downside
10.2%
Sizing output
AVOID
SetupBreakout — Golden cross, above all MAs, RSI 55, MACD bullish
EdgeCatalyst-Driven — Earnings in 25d with 3/4 beat streak
SuitabilityAggressive — MCap $2.5B<$5B
Investment implication
The F-path SELL output reflects an overall score of 4.1 below the 5.6 soft trigger — multiple weakening dimensions accumulated rather than a single hard-floor breach. The strongest dimension ( Value at 7.7) was not enough to lift the adjusted overall above the threshold. Co-occurring failed gates ( ASYMMETRY:0.0<1.5@spot) reinforce the read. Current asymmetry R:R is 0.02 — supplementary context, not the trigger for this path.
The strongest dimensions are Value at 7.7, Growth at 6.8, and Catalyst at 6.7; the weakest are Peer rank at 2.2, Quality at 4.5, and Risk (lower is worse) at 4.7. The V9 engine flagged 1 failed gate with 1 warning, producing an asymmetric reward-to-risk of 0.02 and an engine sizing output of AVOID.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Earnings Beat Execution
Trip ifEPS surprise falls below -10% in at least 2 of the next 4 quarters.
- P2Deep Value Peg Ratio
Trip ifForward P/E falls below 10x due to downward earnings estimate revisions greater than 15%.
- P3Breakout Technical Momentum
Trip ifPrice drops below $68.49 stop-loss level or RSI falls below 40 and on-balance volume declines for 4 consecutive weeks.
- P4Extreme Leverage Balance Sheet Risk
Trip ifDebt-to-equity ratio rises above 40x or interest expense exceeds 40% of operating income in any reported quarter.